Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 171

1.

Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts.

Lang P, Barbin K, Feuchtinger T, Greil J, Peipp M, Zunino SJ, Pfeiffer M, Handgretinger R, Niethammer D, Fey GH.

Blood. 2004 May 15;103(10):3982-5. Epub 2004 Feb 5.

PMID:
14764538
[PubMed - indexed for MEDLINE]
Free Article
2.

Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation.

Pfeiffer M, Stanojevic S, Feuchtinger T, Greil J, Handgretinger R, Barbin K, Jung G, Martin D, Niethammer D, Lang P.

Bone Marrow Transplant. 2005 Jul;36(2):91-7.

PMID:
15908973
[PubMed - indexed for MEDLINE]
3.

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.

Cooper LJ, Topp MS, Serrano LM, Gonzalez S, Chang WC, Naranjo A, Wright C, Popplewell L, Raubitschek A, Forman SJ, Jensen MC.

Blood. 2003 Feb 15;101(4):1637-44. Epub 2002 Oct 10.

PMID:
12393484
[PubMed - indexed for MEDLINE]
Free Article
4.

Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).

Bruenke J, Barbin K, Kunert S, Lang P, Pfeiffer M, Stieglmaier K, Niethammer D, Stockmeyer B, Peipp M, Repp R, Valerius T, Fey GH.

Br J Haematol. 2005 Jul;130(2):218-28.

PMID:
16029450
[PubMed - indexed for MEDLINE]
5.

Immunological aspects of haploidentical stem cell transplantation in children.

Handgretinger R, Lang P, Schumm M, Pfeiffer M, Gottschling S, Demirdelen B, Bader P, Kuci S, Klingebiel T, Niethammer D.

Ann N Y Acad Sci. 2001 Jun;938:340-57; discussion 357-8.

PMID:
11458522
[PubMed - indexed for MEDLINE]
6.

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.

Koehl U, Esser R, Zimmermann S, Tonn T, Kotchetkov R, Bartling T, Sörensen J, Grüttner HP, Bader P, Seifried E, Martin H, Lang P, Passweg JR, Klingebiel T, Schwabe D.

Klin Padiatr. 2005 Nov-Dec;217(6):345-50.

PMID:
16307421
[PubMed - indexed for MEDLINE]
7.

NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.

Moga E, Alvarez E, Cantó E, Vidal S, Rodríguez-Sánchez JL, Sierra J, Briones J.

Exp Hematol. 2008 Jan;36(1):69-77. Epub 2007 Oct 23.

PMID:
17959301
[PubMed - indexed for MEDLINE]
8.

Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity.

Lefterova P, Märten A, Buttgereit P, Weineck S, Scheffold C, Huhn D, Schmidt-Wolf IG.

J Immunother. 2000 May-Jun;23(3):304-10.

PMID:
10838659
[PubMed - indexed for MEDLINE]
9.

Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.

Lang P, Griesinger A, Hamprecht K, Feuchtinger T, Schumm M, Neuhäuser F, Greil J, Martin D, Handgretinger R, Niethammer D.

Hum Immunol. 2004 May;65(5):423-31.

PMID:
15172441
[PubMed - indexed for MEDLINE]
10.

Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-zeta activating signal.

Marin V, Kakuda H, Dander E, Imai C, Campana D, Biondi A, D'Amico G.

Exp Hematol. 2007 Sep;35(9):1388-97. Epub 2007 Jul 25.

PMID:
17656004
[PubMed - indexed for MEDLINE]
11.

Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies.

Barbin K, Stieglmaier J, Saul D, Stieglmaier K, Stockmeyer B, Pfeiffer M, Lang P, Fey GH.

J Immunother. 2006 Mar-Apr;29(2):122-33.

PMID:
16531813
[PubMed - indexed for MEDLINE]
12.

A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study.

Lang P, Schumm M, Greil J, Bader P, Klingebiel T, Müller I, Feuchtinger T, Pfeiffer M, Schlegel PG, Niethammer D, Handgretinger R.

Klin Padiatr. 2005 Nov-Dec;217(6):334-8.

PMID:
16307419
[PubMed - indexed for MEDLINE]
13.

Adoptive cellular immunotherapy with CD19-specific T cells.

Rössig C, Pscherer S, Landmeier S, Altvater B, Jürgens H, Vormoor J.

Klin Padiatr. 2005 Nov-Dec;217(6):351-6.

PMID:
16307422
[PubMed - indexed for MEDLINE]
14.

Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children.

Lang P, Pfeiffer M, Handgretinger R, Schumm M, Demirdelen B, Stanojevic S, Klingebiel T, Köhl U, Kuci S, Niethammer D.

Bone Marrow Transplant. 2002 Mar;29(6):497-502.

PMID:
11960269
[PubMed - indexed for MEDLINE]
Free Article
15.

Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibody.

Csóka M, Strauss G, Debatin KM, Moldenhauer G.

Leukemia. 1996 Nov;10(11):1765-72.

PMID:
8892680
[PubMed - indexed for MEDLINE]
16.

Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.

Torelli GF, Guarini A, Maggio R, Alfieri C, Vitale A, Foà R.

Haematologica. 2005 Jun;90(6):785-92.

PMID:
15951291
[PubMed - indexed for MEDLINE]
Free Article
17.

Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.

Wang W, Nishioka Y, Ozaki S, Jalili A, Verma VK, Hanibuchi M, Abe S, Minakuchi K, Matsumoto T, Sone S.

Lung Cancer. 2009 Jan;63(1):23-31. doi: 10.1016/j.lungcan.2008.04.009. Epub 2008 Jun 3.

PMID:
18524412
[PubMed - indexed for MEDLINE]
18.

IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.

Piloto O, Nguyen B, Huso D, Kim KT, Li Y, Witte L, Hicklin DJ, Brown P, Small D.

Cancer Res. 2006 May 1;66(9):4843-51.

PMID:
16651440
[PubMed - indexed for MEDLINE]
Free Article
19.

Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.

Stangl S, Gross C, Pockley AG, Asea AA, Multhoff G.

Cell Stress Chaperones. 2008 Summer;13(2):221-30. doi: 10.1007/s12192-007-0008-y. Epub 2008 Feb 26.

PMID:
18759005
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.

Lang P, Pfeiffer M, Müller I, Schumm M, Ebinger M, Koscielniak E, Feuchtinger T, Föll J, Martin D, Handgretinger R.

Klin Padiatr. 2006 Nov-Dec;218(6):321-6.

PMID:
17080334
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk